Topical photodynamic therapy is immunosuppressive in humans

British Journal of Dermatology

Volumn 162, Issue 3, 2010, Pages 637-641

  Matthews, Y J ^a   Damian, D L ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Aminolaevulinic acid; Delayed type hypersensitivity; Mantoux; Methyl aminolaevulinate; Visible light

Indexed keywords

AMINOLEVULINIC ACID; METHYL AMINOLEVULINIC ACID; PHOTOSENSITIZING AGENT; TUBERCULIN; UNCLASSIFIED DRUG; IMMUNOSUPPRESSIVE AGENT;

ACTINIC KERATOSIS; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DRUG MECHANISM; ERYTHEMA; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIGHT; MALE; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RED LIGHT; SKIN CANCER; TREATMENT FAILURE; TUBERCULIN TEST; TUMOR IMMUNITY; CHEMICALLY INDUCED; DRUG EFFECTS; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; MIDDLE AGED; PHOTOCHEMOTHERAPY; PROCEDURES; RADIATION RESPONSE; SKIN; SKIN NEOPLASMS; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME; YOUNG ADULT;

ADMINISTRATION, TOPICAL; ADULT; AMINOLEVULINIC ACID; FEMALE; HUMANS; HYPERSENSITIVITY, DELAYED; IMMUNE TOLERANCE; IMMUNOSUPPRESSIVE AGENTS; LIGHT; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; SKIN; SKIN NEOPLASMS; TREATMENT OUTCOME; TUBERCULIN TEST; YOUNG ADULT;

EID: 76949092419     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2009.09562.x     Document Type: Article

References (26)

1. Moloney FJ, Comber H, O'Lorcain P et al. A population-based study of skin cancer incidence and prevalence in renal transplant recipients. Br J Dermatol 2006 154 : 498 504.
2. Fisher MS, Kripke ML. Systemic alteration induced in mice by ultraviolet light irradiation and its relationship to ultraviolet carcinogenesis. Proc Natl Acad Sci USA 1977 74 : 1688 1692.
3. Yoshikawa T, Rae V, Bruins-Slot W et al. Susceptibility to effects of UVB radiation on induction of contact hypersensitivity as a risk factor for skin cancer in humans. J Invest Dermatol 1990 95 : 530 536.
4. Wennberg AM, Stenquist B, Stockfleth E et al. Photodynamic therapy with methyl aminolevulinate for prevention of new skin lesions in transplant recipients: a randomized study. Transplantation 2008 86 : 423 429.
5. Dragieva G, Prinz BM, Hafner J et al. A randomized controlled clinical trial of topical photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratoses in transplant recipients. Br J Dermatol 2004 151 : 196 200.
6. Castano AP, Mroz P, Hamblin MR. Photodynamic therapy and anti-tumour immunity. Nat Rev Cancer 2006 6 : 535 545.
7. Morton CA, McKenna KE, Rhodes LE. Guidelines for topical photodynamic therapy: update. On behalf of the British Association of Dermatologists Therapy Guidelines and Audit Committee and the British Photodermatology Group. Br J Dermatol 2008 159 : 1245 1266.
8. Juzenas P, Juzeniene A, Kaalhus O et al. Noninvasive fluorescence excitation spectroscopy during application of 5-aminolevulinic acid in vivo. Photochem Photobiol Sci 2002 1 : 745 748.
9. Lehmann P. Methyl aminolaevulinate-photodynamic therapy: a review of clinical trials in the treatment of actinic keratoses and nonmelanoma skin cancer. Br J Dermatol 2007 156 : 793 801.
10. Tschen EH, Wong DS, Pariser DM et al. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12 month follow up. Br J Dermatol 2006 155 : 1262 1269.
11. Sharfaei S, Viau G, Lui H et al. Systemic photodynamic therapy with aminolaevulinic acid delays the appearance of ultraviolet-induced skin tumours in mice. Br J Dermatol 2001 144 : 1207 1214.
12. de Graaf YC, Kennedy C, Wolterbeek R et al. Photodynamic therapy does not prevent cutaneous squamous-cell carcinoma in organ transplant recipients: results of a randomized-controlled trial. J Invest Dermatol 2006 126 : 569 574.
13. Elmets CA, Bowen KD. Immunological suppression in mice treated with hematoporphyrin derivative photoradiation. Cancer Res 1986 46 : 1608 1611.
14. Damian DL, Patterson CRS, Stapelberg M et al. Ultraviolet radiation-induced immunosuppression is greater in men and prevented by topical nicotinamide. J Invest Dermatol 2008 128 : 447 454.
15. Fitzpatrick TB. The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol 1998 124 : 869 871.
16. Bouros D, Zeros G, Panaretos C et al. Palpation vs pen method for the measurement of skin tuberculin reaction (Mantoux test). Chest 1991 99 : 416 419.
17. Braathen LR, Szeimies RM, Basset-Seguin N et al. Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005. J Am Acad Dermatol 2007 56 : 125 143.
18. Astner S, Anderson RR. Skin phototypes 2003. J Invest Dermatol 2004 122 : xxx xxxi.
19. Moreno S, Blázquez R, Novoa A et al. The effect of BCG vaccination on tuberculin reactivity and the booster effect among hospital employees. Arch Int Med 2001 161 : 1760 1765.
20. Hayami J, Okamoto H, Sugihara A et al. Immunosuppressive effects of photodynamic therapy by topical aminolevulinic acid. J Dermatol 2007 34 : 320 327.
21. Damian DL, Barnetson RS, Halliday GM. Low-dose UVA and UVB have different time courses for suppression of contact hypersensitivity to a recall antigen in humans. J Invest Dermatol 1999 112 : 939 944.
22. Gollnick SO, Musser DA, Oseroff AR et al. IL-10 does not play a role in cutaneous Photofrin photodynamic therapy-induced suppression of the contact hypersensitivity response. Photochem Photobiol 2001 74 : 811 816.
23. Wong T-W, Tracy E, Oseroff AR et al. Photodynamic therapy mediates immediate loss of cellular responsiveness to cytokines and growth factors. Cancer Res 2003 63 : 3812 3818.
24. Novoselova EG, Glushkova OV, Cherenkov DA et al. Effects of low-power laser radiation on mice immunity. Photodermatol Photoimmunol Photomed 2006 22 : 33 8.
25. Lynch DH, Haddad S, King VJ et al. Systemic immunosuppression induced by photodynamic therapy is adoptively transferred by macrophages. Photochem Photobiol 1989 49 : 453 458.
26. Kabingu E, Vaughan L, Owczarczak B et al. CD8+ T cell-mediated control of distant tumours following local photodynamic therapy is independent of CD4+ T cells and dependent on natural killer cells. Br J Cancer 2007 96 : 1839 1848.